1. Home
  2. HBAN vs RMD Comparison

HBAN vs RMD Comparison

Compare HBAN & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntington Bancshares Incorporated

HBAN

Huntington Bancshares Incorporated

HOLD

Current Price

$15.89

Market Cap

33.3B

Sector

Finance

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$207.25

Market Cap

29.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBAN
RMD
Founded
1866
1989
Country
United States
United States
Employees
24641
10600
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.3B
29.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HBAN
RMD
Price
$15.89
$207.25
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$19.73
$292.56
AVG Volume (30 Days)
18.2M
1.3M
Earning Date
04-23-2026
04-30-2026
Dividend Yield
3.80%
1.13%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$50.83
$10.60
Revenue Next Year
$9.27
$7.41
P/E Ratio
$12.87
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$14.89
$198.61
52 Week High
$19.44
$293.81

Technical Indicators

Market Signals
Indicator
HBAN
RMD
Relative Strength Index (RSI) 47.49 43.72
Support Level $15.07 $198.63
Resistance Level $16.15 $260.21
Average True Range (ATR) 0.33 4.85
MACD -0.02 1.26
Stochastic Oscillator 44.89 62.06

Price Performance

Historical Comparison
HBAN
RMD

About HBAN Huntington Bancshares Incorporated

Huntington is a regional US bank with over $285 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with aging populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: